StockNews.com Initiates Coverage on VolitionRx (NYSE:VNRX)
Stock analysts at StockNews.com started coverage on shares of VolitionRx (NYSE:VNRX – Get Free Report) in a research note issued to investors on Saturday. The brokerage set a “sell” rating on the stock. Several other equities analysts have also weighed in on VNRX. D. Boral Capital reaffirmed a “buy” rating and issued a $5.00 price […]
![StockNews.com Initiates Coverage on VolitionRx (NYSE:VNRX)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/volitionrx-limited-logo-1200x675.png?v=20240611125319&w=240&h=240&zc=2)